Further understanding of the factors that control the secretory trafficking of ATZ is important toward the clinical treatment of ATD, with discoveries benefitting those suffering from lung and liver malfunction due to faulty trafficking of defective AAT. Here, SERPINA1 is linked to Jeune syndrome.